Scenario modelling for diminished influenza seasons during 2020/2021 and 2021/2022 in England
Hill, E. M.; Keeling, M. J.
Show abstract
BackgroundThere has been concern throughout the COVID-19 pandemic over highly stressed healthcare capacities being further pressured by seasonal influenza epidemics. Interventions to tackle the spread of SARS-CoV-2, the causative agent of COVID-19, have unsettled the respiratory pathogen landscape, including worldwide patterns of influenza activity. The implications of these disruptions for subsequent influenza seasons has been uncertain. MethodsTo conduct scenario analyses ahead of the 2020/2021 and 2021/2022 influenza seasons in England, we used a pre-existing age-structured, multi-strain compartmental model of influenza transmission and case severity, which included propagation of immunity between influenza seasons and had been previously fit to historical data. For the pre-2020/2021 influenza season, our scenarios varied the level of vaccine uptake and the inclusion/exclusion of nonpharmaceutical interventions (NPIs). We estimated the relative amount of health episode occurrences: symptomatic cases resulting in a GP consultation, hospital inpatient admissions, fatalities. In the pre-2021/2022 influenza season analysis, compared with a counterfactual case where influenza activity remained at historic levels in the 2020/2021 influenza season, we estimated the change in the same set of health episode occurrences in the 2021/2022 influenza season when assuming there was no influenza in circulation during the 2020/2021 influenza season. ResultsAttaining coverage of 75% in target groups for the 2020/2021 influenza season reduced health episode occurrences by 40-50% when compared to maintaining the 2019/2020 vaccination programme coverage and uptake levels. Having NPIs maintained throughout the entire influenza season saw 60-80% reductions in severe case outcomes. Combining an expanded vaccination programme and the use of NPIs could suppress the seasonal influenza epidemic, with reductions as much as 90-100%. In the absence of influenza transmission during the 2020/2021 influenza season, under our modelling assumption of mixing patterns returning to pre-2020 levels we projected a compensatory influenza epidemic with 1.2 to 2.2 times as many severe health episode occurrences in the subsequent 2021/2022 influenza season. ConclusionsIn the context of the time the work was originally conducted, the modelled scenarios indicated how bolstering vaccine coverage and reduction in contacts could likely allay resurgent seasonal influenza epidemics. Our analyses of the winter pressures that may be inflicted by other respiratory infections during the COVID-19 pandemic are one example of the modelling insights provided to the Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O) for the Scientific Advisory Group for Emergencies (SAGE) in the UK.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Using real-time data to guide decision-making during an influenza pandemic: a modelling analysis 97%
- Seasonal influenza: Modelling approaches to capture immunity propagation 97%
- Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation 97%
Similar papers in this journal
- Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a ‘National Plan’ to reopening 97%
- The COVID-19 vaccination campaign in Switzerland and its impact on disease spread 96%
- Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data 95%
Similar papers in this journal
- An assessment of the vaccination of school-aged children in England 96%
- Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study 96%
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 95%
Similar papers in this journal
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 96%
- Modelling the impact of hybrid immunity on future COVID-19 epidemic waves 96%
- Predicting subnational incidence of COVID-19 cases and deaths in EU countries 94%
Similar papers in this journal
- Exploring the role of mass immunisation in influenza pandemic preparedness: a modelling study for the UK context 97%
- Cost-effectiveness of routine COVID-19 adult vaccination programmes in England 96%
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.